{"cluster": 37, "subcluster": 14, "abstract_summ": "Seventy-eight patients (36.4%) displayed neurological symptoms, including central nervous system symptoms of dizziness, headache, impaired consciousness, acute cerebrovascular disease with either ischemic stroke or cerebral hemorrhage, ataxia, seizures; peripheral nervous system symptoms of taste impairment, smell impairment, vision impairment, and nerve pain; and skeletal muscle injury (Mao, 2020).Recently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic.[Figure: see text]Coronavirus Disease 2019 (COVID-19) can be associated with various neurological manifestations including acute strokes.It typically presents with mild upper respiratory tract infection symptoms and may have life threatening complications, including acute respiratory distress syndrome, acute stroke, myocardial infarction, kidney failure, shock, and even death.In the series by Ling M. et al., 214 patients with COVID-19 were studied; 78 (36.4 %) had neurologic manifestations, which were classified into four main groups: acute cerebrovascular disease, impaired consciousness, peripheral nervous system involvement and muscular manifestations.Another report published by Li et al. describes that, out of 221 patients with COVID-19, 13 developed acute cerebrovascular disease with cerebral infarction, venous thrombosis and intracerebral hemorrhage.", "title_summ": "Neurological manifestations of COVID-19.Cerebellar Scholars\u2019 Challenging Time in COVID-19 PandemiaCoexistence of Covid-19 and Acute Ischemic Stroke Report of Four CasesExplanation for COVID\u201019 infection neurological damage and reactivationsReversible Encephalopathy Syndrome (PRES) in a COVID-19 patientSpectrum of Neuropsychiatric Manifestations in COVID-19Neurological Manifestations of COVID\u201019: A systematic review and current updateSeizures associated with coronavirus infectionsSARS-CoV-2 Infection Leads to Neurological DysfunctionLocked-In with COVID-19", "title_abstract_phrases": "Seventy-eight patients (36.4%) displayed neurological symptoms, including central nervous system symptoms of dizziness, headache, impaired consciousness, acute cerebrovascular disease with either ischemic stroke or cerebral hemorrhage, ataxia, seizures; peripheral nervous system symptoms of taste impairment, smell impairment, vision impairment, and nerve pain; and skeletal muscle injury (Mao, 2020).Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patientRecently WHO has declared novel coronavirus disease 2019 (COVID-19) outbreak a pandemic.It typically presents with mild upper respiratory tract infection symptoms and may have life threatening complications, including acute respiratory distress syndrome, acute stroke, myocardial infarction, kidney failure, shock, and even death.In the series by Ling M. et al., 214 patients with COVID-19 were studied; 78 (36.4 %) had neurologic manifestations, which were classified into four main groups: acute cerebrovascular disease, impaired consciousness, peripheral nervous system involvement and muscular manifestations.[Figure: see text]Locked-In with COVID-19Coronavirus Disease 2019 (COVID-19) can be associated with various neurological manifestations including acute strokes.Besides pneumonia, it has been demonstrated that SARS-CoV-2 infection affects multiple organs, including brain tissues, causing different neurological manifestations, especially acute cerebrovascular disease (ischemic and hemorrhagic stroke), impaired consciousness and skeletal muscle injury."}